Price Intelligence PRO

MedInfoBase Intelligence PRO

Pakistan Pharmaceutical Price Intelligence

Benchmark official medicine prices against like-for-like products, monitor price history and turn MedInfoBase regulatory-source data into decision-ready competitive intelligence.

20,581Priced products
0Comparator groups indexed
0Price positions indexed
24,279Price observations retained
← New searchPrice benchmark

D-Plasmo DS 80 mg + 480 mg

Artemether + Lumefantrine · Tablet · Next Pharmaceutical Products (Pvt.) Ltd

Open full product record →
Official pack pricePKR 568.796's
Normalized unit pricePKR 94.80/ tablet
Price position13% below median98 peer comparators
🔒
Pharma Pro

Unlock the complete competitor benchmark

See the exact comparator median, min/max and quartiles, product rank, price percentile and the full like-for-like competitor table.

✓ Rank & percentile✓ Comparator median✓ Competitor brands✓ Portfolio intelligence
Subscribe to unlock
Subscription

Choose the intelligence level your team needs.

Basic official price information and the public price-position signal remain accessible. Pharma Pro adds the detailed analytical benchmark used for competitive price review.

Free

Public access

PKR 0

For healthcare professionals, students and general users.

  • Official listed price
  • Normalized unit price
  • Basic above / near / below median signal
Browse medicines
Enterprise / API

Enterprise data licensing

Custom

For company-wide access and organizations planning software or data integration.

  • Enterprise licensing discussion
  • API access roadmap
  • Usage limits by agreement
  • Integration planning
Discuss enterprise access

Pharma Pro annual reference price: PKR 250,000. Annual access can be offered as a discounted commercial plan.

Built for defensible comparison

Like-for-like groups

Products are compared only within the same canonical generic, stated strength, dosage form and compatible normalized unit basis.

Historical source trail

MedInfoBase retains price history instead of overwriting prior observations, allowing future change intelligence and audit-ready comparisons.

Price position—not market share

These metrics describe official listed price position. They do not claim sales, prescription volume, revenue, demand or market share.